Antisense RNA transcripts in the blood may be novel diagnostic markers for colorectal cancer

Kurokawa,Tomohiro; Kohno,Keisuke; Nagai,Kentaro; Chiba,Mitsuru; Pak,Sugiru; Murata,Soichiro; Fukunaga,Kiyoshi; Yasue,Hiroshi; Ohkohchi,Nobuhiro

doi:10.3892/ol.2017.6572

Antisense RNA transcripts in the blood may be novel diagnostic markers for colorectal cancer

Authors:
- Tomohiro Kurokawa
- Keisuke Kohno
- Kentaro Nagai
- Mitsuru Chiba
- Sugiru Pak
- Soichiro Murata
- Kiyoshi Fukunaga
- Hiroshi Yasue
- Nobuhiro Ohkohchi
View Affiliations

Affiliations: Department of Gastrointestinal and Hepato‑Biliary‑Pancreatic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305‑8575, Japan, Department of Biomedical Sciences, Division of Medical Life Sciences, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036‑8564, Japan, Genome Resource Unit, National Institute of Agrobiological Sciences, Tsukuba, Ibaraki 305‑0901, Japan
Published online on: July 15, 2017 https://doi.org/10.3892/ol.2017.6572
Pages: 3487-3493
Copyright: © Kurokawa et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Numerous genetic studies have been conducted regarding the occurrence of colorectal cancer (CRC) and the prognosis using microarrays. However, adequate investigations into the diagnostic application of microarrays have yet to be performed. The simplicity and accuracy of diagnosis and prognosis tracking are important requirements for its processes, and the use of blood cells for diagnosis is considered to be suitable to meet these requirements. The patients involved in the study were 28 preoperative patients with CRC and 6 healthy individuals who served as controls. RNA was extracted from the blood cells of the patients and analyzed using a sense/antisense RNA custom microarray. In the patients with CRC, the expression levels of 20 sense RNA and 20 antisense RNA species were identified as being significantly altered compared with that of the healthy volunteers (P<0.05; fold‑change, >2.0). Cluster analysis of these RNA species revealed that the top 10 antisense RNAs significantly clustered patients with cancer and healthy individuals separately. Patients with stage I or II CRC exhibited significant changes in the expression levels of 33 sense and 39 antisense RNA species, as compared with healthy volunteers (P<0.01; fold‑change >2.0). Cluster analysis demonstrated that patients with stage I or II CRC and healthy volunteers formed separate clusters only among the top 20 antisense RNA species. A tracking study of expression levels of haloacid dehalogenase‑like hydrolase domain‑containing 1 (HDHD1) antisense RNA was performed and a significant difference was identified between the CRC and healthy groups revealing that the levels at one week and three months following surgical removal of the cancerous tissue, decreased to almost same levels of the healthy individuals. The results of the current study indicate that HDHD1 antisense RNA may serve as a potential biomarker for the prognosis of CRC.

View Figures

View References

1	Jemal A, Siegel R, Xu J and Ward E: Cancer Statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
2	Malvezzi M, Bertuccio P, Levi F, La Vecchia C and Negri E: European cancer mortality predictions for the year 2014. Ann Oncol. 25:1650–1656. 2014. View Article : Google Scholar : PubMed/NCBI
3	Tsukuma H, Ajiki W and Oshima A: Cancer incidence in Japan. Gan To Kagaku Ryoho. 31:840–846. 2004.(In Japanese). PubMed/NCBI
4	Koehler A, Bataille F, Schmid C, Ruemmele P, Waldeck A, Blaszyk H, Hartmann A, Hofstaedter F and Dietmaier W: Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage. J Pathol. 204:65–74. 2004. View Article : Google Scholar : PubMed/NCBI
5	Croner RS, Foertsch T, Brueckl WM, Guenther K, Siebenhaar R, Stremmel C, Matzel KE, Papadopoulos T, Kirchner T, Behrens J, et al: Common denominator genes that distinguish colorectal carcinoma from normal mucosa. Int J Colorectal Dis. 20:353–362. 2005. View Article : Google Scholar : PubMed/NCBI
6	Raetz EA and Moos PJ: Impact of microarray technology in clinical oncology. Cancer Invest. 22:312–320. 2004. View Article : Google Scholar : PubMed/NCBI
7	Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K and Mori M: Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res. 12:3057–3063. 2006. View Article : Google Scholar : PubMed/NCBI
8	Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, Ginestier C, Charafe-Jauffret E, Loriod B, Bachelart L, Montfort J, et al: Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene. 23:1377–1391. 2004. View Article : Google Scholar : PubMed/NCBI
9	Bianchini M, Levy E, Zucchini C, Pinski V, Macagno C, De Sanctis P, Valvassori L, Carinci P and Mordoh J: Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa. Int J Oncol. 29:83–94. 2006.PubMed/NCBI
10	Birkenkamp-Demtroder K, Christensen LL, Olesen SH, Frederiksen CM, Laiho P, Aaltonen LA, Laurberg S, Sørensen FB, Hagemann R and ØRntoft TF: Gene expression in colorectal cancer. Cancer Res. 62:4352–4363. 2002.PubMed/NCBI
11	Lawlor KG, Telang NT, Osborne MP, Schaapveld RQ, Cho KR, Vogelstein B and Narayanan R: Antisense RNA to the putative tumor suppressor gene ‘deleted in colorectal cancer’ transforms fibroblasts. Ann N Y Acad Sci. 660:283–285. 1992. View Article : Google Scholar : PubMed/NCBI
12	Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
13	Grigoriadis A, Oliver GR, Tanney A, Kendrick H, Smalley MJ, Jat P and Neville AM: Identification of differentially expressed sense and antisense transcript pairs in breast epithelial tissues. BMC Genomics. 10:3242009. View Article : Google Scholar : PubMed/NCBI
14	Kohno K, Chiba M, Murata S, Pak S, Nagai K, Yamamoto M, Yanagisawa K, Kobayashi A, Yasue H and Ohkohchi N: Identification of natural antisense transcripts involved in human colorectal cancer development. Int J Oncol. 37:1425–1432. 2010.PubMed/NCBI
15	Nagai K, Kohno K, Chiba M, Pak S, Murata S, Fukunaga K, Kobayashi A, Yasue H and Ohkohchi N: Differential expression profiles of sense and antisense transcripts between HCV-associated hepatocellular carcinoma and corresponding non-cancerous liver tissue. Int J Oncol. 40:1813–1820. 2012.PubMed/NCBI
16	Chiba M, Kimura M and Asari S: Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines. Oncol Rep. 28:1551–1558. 2012.PubMed/NCBI
17	Benjamini Y and Hochberg Y: Controling the false discovery rate: A pratical and powerful approach to multiple testing. J R Statist Soc. 57:289–300. 1995.
18	Ward JH Jr: Hierarchical grouping to optimize an objective function. J Am Stat Assoc. 58:236–244. 1963. View Article : Google Scholar
19	Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, Radich J, Anderson G and Hartwell L: The case for early detection. Nat Rev Cancer. 3:243–252. 2003. View Article : Google Scholar : PubMed/NCBI
20	Hundt S, Haug U and Brenner H: Blood markers for early detection of colorectal cancer: A systematic review. Cancer Epidemiol Biomarkers Prev. 16:1935–1953. 2007. View Article : Google Scholar : PubMed/NCBI
21	Yoshigai E, Hara T, Araki Y, Tanaka Y, Oishi M, Tokuhara K, Kaibori M, Okumura T, Kwon AH and Nishizawa M: Natural antisense transcript-targeted regulation of inducible nitric oxide synthase mRNA levels. Nitric Oxide. 30:9–16. 2013. View Article : Google Scholar : PubMed/NCBI
22	Robb GB, Carson AR, Tai SC, Fish JE, Singh S, Yamada T, Scherer SW, Nakabayashi K and Marsden PA: Post-transcriptional regulation of endothelial nitric-oxide synthase by an overlapping antisense mRNA transcript. J Biol Chem. 279:37982–37996. 2004. View Article : Google Scholar : PubMed/NCBI
23	Camblong J, Iglesias N, Fickentscher C, Dieppois G and Stutz F: Antisense RNA stabilization induces transcriptional gene silencing via histone deacetylation in S. Cerevisiae. Cell. 131:706–717. 2007. View Article : Google Scholar : PubMed/NCBI
24	Faghihi MA, Zhang M, Huang J, Modarresi F, Van der Brug MP, Nalls MA, Cookson MR, St-Laurent G III and Wahlestedt C: Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol. 11:R562010. View Article : Google Scholar : PubMed/NCBI
25	Carrieri C, Cimatti L, Biagioli M, Beugnet A, Zucchelli S, Fedele S, Pesce E, Ferrer I, Collavin L, Santoro C, et al: Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature. 491:454–457. 2012. View Article : Google Scholar : PubMed/NCBI